Drawing for OFTALMI

USPTO serial 76585570

OFTALMI

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
HARDY LUDLOW, TARAH KIM
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with OFTALMI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005pharmaceuticals for treatment of ophthalmic conditions; eyedrops; dietary supplementsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 20, 2007MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 20, 2007ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 5, 2006EX3GSOU EXTENSION 3 GRANTED
Oct 5, 2006EXT3SOU EXTENSION 3 FILED
Oct 5, 2006EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 5, 2006EX2GSOU EXTENSION 2 GRANTED
Apr 5, 2006EXT2SOU EXTENSION 2 FILED
Apr 5, 2006EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 5, 2005EX1GSOU EXTENSION 1 GRANTED
Oct 5, 2005EXT1SOU EXTENSION 1 FILED
Oct 5, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 5, 2005NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 11, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 22, 2004NPUBNOTICE OF PUBLICATION
Nov 10, 2004MAILPAPER RECEIVED
Nov 2, 2004PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 29, 2004ALIEASSIGNED TO LIE
Oct 27, 2004CNEAEXAMINER'S AMENDMENT MAILED
Oct 27, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 27, 2004CNEAEXAMINERS AMENDMENT -WRITTEN
Oct 25, 2004DOCKASSIGNED TO EXAMINER
May 26, 2004AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
May 26, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 26, 2004MAILPAPER RECEIVED
Apr 26, 2004NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance